A Phase II Study of Erythropoietin for Management of Anemia Caused by Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Darbepoetin alfa (Primary) ; Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms EPOMA
- 30 Aug 2017 Planned End Date changed from 1 Dec 2017 to 31 Dec 2017.
- 30 Aug 2017 Planned primary completion date changed from 1 Dec 2016 to 31 Dec 2017.
- 24 Sep 2016 New trial record